Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1069

1.

Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.

Becerra EM, Morescalchi F, Gandolfo F, Danzi P, Nascimbeni G, Arcidiacono B, Semeraro F.

Curr Drug Targets. 2011 Feb;12(2):149-72. Review.

PMID:
20887246
[PubMed - indexed for MEDLINE]
2.

Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

Chaudhary V, Mao A, Hooper PL, Sheidow TG.

Ophthalmology. 2007 Dec;114(12):2183-9.

PMID:
18054638
[PubMed - indexed for MEDLINE]
3.

Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.

PMID:
16996600
[PubMed - indexed for MEDLINE]
4.

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U.

Am J Ophthalmol. 2006 Apr;141(4):638-45.

PMID:
16564797
[PubMed - indexed for MEDLINE]
5.
6.

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

Spaide RF, Sorenson J, Maranan L.

Ophthalmology. 2003 Aug;110(8):1517-25.

PMID:
12917166
[PubMed - indexed for MEDLINE]
7.

Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.

Frimpong-Boateng A, Bunse A, Rüfer F, Roider J.

Acta Ophthalmol. 2009 Mar;87(2):183-7. doi: 10.1111/j.1755-3768.2008.01213.x. Epub 2008 Jun 11.

PMID:
18547278
[PubMed - indexed for MEDLINE]
8.

Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

Schadlu R, Kymes SM, Apte RS.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.

PMID:
17583819
[PubMed - indexed for MEDLINE]
9.

Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

Am J Ophthalmol. 2006 Jul;142(1):10-16.

PMID:
16815246
[PubMed - indexed for MEDLINE]
10.

Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.

Spielberg L, Leys A.

Graefes Arch Clin Exp Ophthalmol. 2010 Jul;248(7):943-56. doi: 10.1007/s00417-009-1256-6. Epub 2010 Mar 4.

PMID:
20204659
[PubMed - indexed for MEDLINE]
11.

Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

Spaide RF, Sorenson J, Maranan L.

Ophthalmology. 2005 Feb;112(2):301-4.

PMID:
15691567
[PubMed - indexed for MEDLINE]
12.

[ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].

Gamulescu MA, Schubert K, Thormann S, Attaran M, Dueck N, Wiechens B, Spital G, Stroux A, Wachtlin J.

Klin Monbl Augenheilkd. 2009 Jan;226(1):60-5. doi: 10.1055/s-2008-1027729. Epub 2009 Jan 27. German.

PMID:
19173165
[PubMed - indexed for MEDLINE]
13.

Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.

Iwama D, Otani A, Sasahara M, Yodoi Y, Gotoh N, Tamura H, Tsujikawa A, Yoshimura N.

Br J Ophthalmol. 2008 Oct;92(10):1352-6. doi: 10.1136/bjo.2008.141754. Epub 2008 Jul 28.

PMID:
18662914
[PubMed - indexed for MEDLINE]
15.

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U.

Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.

PMID:
16360209
[PubMed - indexed for MEDLINE]
16.

Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

Kourlas H, Abrams P.

Clin Ther. 2007 Sep;29(9):1850-61. Review.

PMID:
18035187
[PubMed - indexed for MEDLINE]
17.

[Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].

Mozolewska-Piotrowska K, Krzystolik K, Karczewicz D, Drobek-Słowik M, Kubasik-Kładna K.

Klin Oczna. 2011;113(7-9):233-6. Polish.

PMID:
22256564
[PubMed - indexed for MEDLINE]
18.

Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.

PMID:
17152538
[PubMed - indexed for MEDLINE]
19.

Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.

Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

Arch Ophthalmol. 2009 Mar;127(3):275-81. doi: 10.1001/archophthalmol.2008.602.

PMID:
19273790
[PubMed - indexed for MEDLINE]
20.

Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.

PMID:
22350060
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk